FDA Investigator Kenya Destin
Kenya Destin has inspections in 1 countries as of 24 Apr 2024. Kenya Destin has collaborated with a combined 791 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
24 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams,
Adam S Freeman,
Alford R Taylor,
Amogh Pathi,
Anderson,
Andrea P Scott,
Carl Lee,
CDR Sean T Creighton,
Christine M Parmentier,
Christopher W Buser,
Elizabeth A Dakan,
Emma R Schaefer,
Eric J Heinze,
Eric W Anderson,
Francis J Eng,
Ivar J Sohn,
James A Lane,
James R Fleckenstein,
Janet Pulver,
Jeffrey S Buckser,
Jesse A Vazquez,
Jessica E Paulsen,
Jocelyn T Ramos,
Joseph A Seitz,
Juanita Banuelos,
Jude C Dikes,
Kelvin Cheung,
Lance A Finnical,
Lawton W Lum,
Leonard H Lavi,
Linda Linhn Adams,
Linda S Shook,
Maida Henesian (NMI),
Mark E Chan,
Mary R Hole,
Matthew D Schnittker,
Melissa A Torres,
Nicole M Gillette,
Phillip M Pontikos,
Sara M Richardson,
Seema S Singh,
Sherri J Jackson,
State Agency,
Suzanne M Healy,
Thea C Grome,
Timothy C Grome,
Uttaniti Limchumroon (Tom)
Kenya Destin's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2022 | FDA 483 | Olympus Corporation of the Americas - Form 483, 2022-03-10 |
October, 2021 | FDA 483 | ITG-Medev, Inc. - Form 483, 2021-10-22 |
December, 2022 | FDA 483 | Siesta Medical, Inc. - Form 483, 2022-12-15 |
March, 2023 | FDA 483 | BIGFOOT BIOMEDICAL - Form 483, 2023-03-21 |
May, 2023 | FDA 483 | Gener8 - Form 483, 2023-05-05 |
December, 2022 | FDA 483 | Echopixel, Inc. - Form 483, 2022-12-02 |
September, 2022 | FDA 483 | Intuitive Surgical, Inc. - Form 483, 2022-09-29 |
December, 2021 | FDA 483 | Viewray, Inc. - Form 483, 2021-12-16 |
August, 2023 | FDA 483 | Infinity Labs SD, Inc - Form 483, 2023-08-21 |
June, 2023 | FDA 483 | Abbott Medical - Form 483, 2023-06-28 |
June, 2023 | FDA 483 Response | Abbott Medical - Form 483R, 2023-06-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more